San Francisco Sentry Investment Group’s Organon & Co OGN Stock Holding History

San Francisco Sentry Investment Group’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$16K	Buy	+535	New	+$17.6K	0.01%	488

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

San Francisco Sentry Investment Group's OGN Position: Q2 2021 in Review

San Francisco Sentry Investment Group opened a new position in Organon & Co (OGN) in Q2 2021: 535 shares worth $16K. The stake represents 0.01% of the portfolio and ranks #488 among its holdings.

988 funds tracked by Wall St. Rank hold OGN as of Q2 2021.

San Francisco Sentry Investment Group held 535 shares of Organon & Co worth $16K as of Q2 2021.
Organon & Co was a new San Francisco Sentry Investment Group position in Q2 2021.
Organon & Co made up 0.01% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #488 holding.
988 funds tracked by Wall St. Rank held Organon & Co as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.